Related Experiment Videos
[Drug therapy in impaired liver and kidney function]
Schweizerische Medizinische Wochenschrift
|May 21, 1983
Summary
Adjusting drug dosage for patients with impaired renal function requires quantitative methods for dose calculation. However, assessing drug indications and therapeutic effects in renal or hepatic failure necessitates a qualitative approach.
Area of Science:
- Pharmacology
- Nephrology
- Hepatology
Context:
- Altered drug indications, dosages, and adverse effect risks in patients with impaired renal function.
- Hepatic failure presents similar challenges to drug management as renal impairment.
Purpose:
- To outline methods for adjusting drug dosages in patients with renal impairment.
- To describe the qualitative approach needed for assessing drug indications and effects in renal and hepatic failure.
Summary:
- Quantitative mathematical tools allow for "a priori" drug dose adjustments based on renal function.
- Qualitative assessments are necessary for evaluating drug indications and monitoring pharmacotherapy effects in renal and hepatic impairment.
- Unlike renal impairment, no quantitative rules exist for reducing "a priori" drug doses in hepatic failure.
Impact:
- Enables safer and more effective pharmacotherapy in patients with kidney and liver dysfunction.
- Highlights the limitations of quantitative dosing in complex organ failure scenarios.
- Informs clinical practice regarding drug management in compromised renal and hepatic function.